The impact of disease burden: Understanding patient priorities in aRCC

Global oncology innovations: B.J. Kennedy award for geriatric oncology

DVRd improves MRD negativity and PFS in transplant ineligible newly diagnosed multiple myeloma

Subcutaneous blinatumomab plus TKI drives high remission in relapsed Ph+ acute lymphoblastic leukaemia

Risk model predicts relapse after frontline blinatumomab in paediatric B-ALL

Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving survival

Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer

Understanding patient expectations and clinicians' goals in favourable risk aRCC patients

Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer

Talazoparib plus enzalutamide improves radiographic progression-free survival in HRR-altered mCSPC

1: Safe administration and dosing of EGFR inhibitors in NSCLC - Practical guidance for oncology nurses

2: Managing EGFR inhibitor side effects in NSCLC - Skin toxicity impact, adherence challenges, and nursing management